BR9402149A - Processo para a preparação da forma cristalina monohidratada de um composto - Google Patents
Processo para a preparação da forma cristalina monohidratada de um compostoInfo
- Publication number
- BR9402149A BR9402149A BR9402149A BR9402149A BR9402149A BR 9402149 A BR9402149 A BR 9402149A BR 9402149 A BR9402149 A BR 9402149A BR 9402149 A BR9402149 A BR 9402149A BR 9402149 A BR9402149 A BR 9402149A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- preparation
- crystalline form
- monohydrate crystalline
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/071,550 US5374719A (en) | 1993-06-04 | 1993-06-04 | Process for converting loracarbef dihydrate to loracarbef monohydrate |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9402149A true BR9402149A (pt) | 1994-12-27 |
Family
ID=22102051
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9402149A BR9402149A (pt) | 1993-06-04 | 1994-06-01 | Processo para a preparação da forma cristalina monohidratada de um composto |
Country Status (29)
Country | Link |
---|---|
US (1) | US5374719A (pt) |
EP (1) | EP0627430B1 (pt) |
JP (1) | JP3442479B2 (pt) |
KR (1) | KR100311699B1 (pt) |
CN (1) | CN1042424C (pt) |
AT (1) | ATE146472T1 (pt) |
AU (1) | AU678000B2 (pt) |
BR (1) | BR9402149A (pt) |
CA (1) | CA2125001C (pt) |
CO (1) | CO4230100A1 (pt) |
CZ (1) | CZ283468B6 (pt) |
DE (1) | DE69401163T2 (pt) |
DK (1) | DK0627430T3 (pt) |
ES (1) | ES2097002T3 (pt) |
FI (1) | FI108132B (pt) |
GR (1) | GR3022111T3 (pt) |
HU (1) | HU217066B (pt) |
IL (1) | IL109871A (pt) |
MY (1) | MY110724A (pt) |
NO (1) | NO306302B1 (pt) |
NZ (1) | NZ260653A (pt) |
PE (1) | PE13195A1 (pt) |
PH (1) | PH30304A (pt) |
PL (1) | PL174539B1 (pt) |
RU (1) | RU2124013C1 (pt) |
TW (1) | TW252980B (pt) |
UA (1) | UA27812C2 (pt) |
YU (1) | YU33394A (pt) |
ZA (1) | ZA943827B (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5550231A (en) * | 1993-06-15 | 1996-08-27 | Eli Lilly And Company | Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof |
US5580977A (en) * | 1995-03-01 | 1996-12-03 | Eli Lilly And Company | Process for preparing loracarbef monohydrate |
US20070225285A1 (en) * | 2005-11-04 | 2007-09-27 | Amira Pharmaceuticals, Inc. | 5-lipoxygenase-activating protein (flap) inhibitors |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3531481A (en) * | 1969-04-21 | 1970-09-29 | Lilly Co Eli | Method for manufacture of crystalline cephalosporin |
US3502663A (en) * | 1969-04-21 | 1970-03-24 | Lilly Co Eli | Crystalline cephalosporin,method for its manufacture |
EG18529A (en) * | 1987-10-06 | 1993-04-30 | Lilly Co Eli | Process for preparing b-lactam hydrate |
CA2002596A1 (en) * | 1988-11-14 | 1990-05-14 | Thomas M. Eckrich | Hydrates of b-lactam antibiotic |
US4977257A (en) * | 1988-11-14 | 1990-12-11 | Eli Lilly And Company | DMF solvates of a β-lactam antibiotic |
-
1993
- 1993-06-04 US US08/071,550 patent/US5374719A/en not_active Expired - Lifetime
-
1994
- 1994-06-01 TW TW083105006A patent/TW252980B/zh active
- 1994-06-01 CZ CZ941342A patent/CZ283468B6/cs not_active IP Right Cessation
- 1994-06-01 PE PE1994243644A patent/PE13195A1/es not_active Application Discontinuation
- 1994-06-01 AT AT94303945T patent/ATE146472T1/de not_active IP Right Cessation
- 1994-06-01 DK DK94303945.3T patent/DK0627430T3/da active
- 1994-06-01 PL PL94303676A patent/PL174539B1/pl not_active IP Right Cessation
- 1994-06-01 NZ NZ260653A patent/NZ260653A/en unknown
- 1994-06-01 ZA ZA943827A patent/ZA943827B/xx unknown
- 1994-06-01 BR BR9402149A patent/BR9402149A/pt not_active Application Discontinuation
- 1994-06-01 DE DE69401163T patent/DE69401163T2/de not_active Expired - Fee Related
- 1994-06-01 ES ES94303945T patent/ES2097002T3/es not_active Expired - Lifetime
- 1994-06-01 EP EP94303945A patent/EP0627430B1/en not_active Expired - Lifetime
- 1994-06-02 NO NO942048A patent/NO306302B1/no not_active IP Right Cessation
- 1994-06-02 UA UA94005241A patent/UA27812C2/uk unknown
- 1994-06-02 MY MYPI94001408A patent/MY110724A/en unknown
- 1994-06-02 CA CA002125001A patent/CA2125001C/en not_active Expired - Fee Related
- 1994-06-02 CO CO94023737A patent/CO4230100A1/es unknown
- 1994-06-02 AU AU64516/94A patent/AU678000B2/en not_active Ceased
- 1994-06-02 KR KR1019940012340A patent/KR100311699B1/ko not_active IP Right Cessation
- 1994-06-02 IL IL10987194A patent/IL109871A/en not_active IP Right Cessation
- 1994-06-02 PH PH48386A patent/PH30304A/en unknown
- 1994-06-03 RU RU94019424A patent/RU2124013C1/ru not_active IP Right Cessation
- 1994-06-03 CN CN94106984A patent/CN1042424C/zh not_active Expired - Fee Related
- 1994-06-03 FI FI942633A patent/FI108132B/fi not_active IP Right Cessation
- 1994-06-03 HU HU9401675A patent/HU217066B/hu not_active IP Right Cessation
- 1994-06-03 JP JP12228394A patent/JP3442479B2/ja not_active Expired - Fee Related
- 1994-06-03 YU YU33394A patent/YU33394A/sh unknown
-
1996
- 1996-12-19 GR GR960403422T patent/GR3022111T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT96916A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo um macrolido | |
NO874350L (no) | Fremgangsmaate for fremstilling av antibakterielle forbindelser. | |
FI931855A (fi) | Farmaceutisk sammansaettning som innehaoller kinolin- och kinazolinderivat samt nya foereningar daerfoer | |
BR9105424A (pt) | Processo para preparacao de um composto pesticida | |
BR9402148A (pt) | Processo para a preparação da forma cristalina monohidratada de um composto, forma cristalina e composto | |
BR9402149A (pt) | Processo para a preparação da forma cristalina monohidratada de um composto | |
ES2179900T3 (es) | Derivados de aminoquinazolinonas (tionas) sustituidos y sus sales, sus intermediarios y pesticidas y metodo para su utilizacion. | |
MX9100345A (es) | Procedimiento para la preparacion de derivados 6-(aminopropionil sustituidos)de forscolina | |
SE8704542D0 (sv) | New derivatives of cysteine | |
PT92668A (pt) | Processo para a preparacao de derivados de azabiciclo-heptano | |
PT837066E (pt) | Processo aperfeicoado para a producao de ester de penicilina g |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EG | Technical examination (opinion): publication of technical examination (opinion) | ||
FC | Decision: refusal |